How did a small profit through nine months turn into a full-year loss?

The company reported a **₹2.31 crore** net loss in the fourth quarter alone. That single quarter's loss exceeded the marginal profit earned from April through December, pushing the full-year figure to a **₹2.20 crore** loss.

How does the FY26 loss compare to the prior year?

The net loss widened from **₹1.46 crore** in FY25 to **₹2.20 crore** in FY26, a **51%** increase, while revenue was flat at **₹53.84 crore**.

Did the auditors raise any flags?

No. The statutory auditors issued an unmodified opinion, meaning they found the financial statements to be presented fairly in all material respects.

What is the company's market capitalization?

Centenial Surgical Suture is a nano-cap with a market capitalization of **₹33 crore**.

Earnings · Medical Equipment · Micro cap

Centenial Surgical Suture posts a ₹2.2 cr annual loss on flat revenue

A ₹2.31 crore fourth-quarter loss wiped out the small profit earned through the first nine months. Full-year revenue held flat at ₹53.84 crore.

— 1 earlier story on Centenial Surgical Suture Ltd. →

CSURGSU By Tipsheet Editorial 30 May 2026 · 9:35 PM IST Verify on BSE · NSE

Mkt cap₹26.71 cr

ROE0.00%

Debt / eq.0.40

₹2.20 cr Net loss for FY26, up from ₹1.46 cr a year ago

What's new

Full-year revenue was flat at ₹53.84 crore, but the net loss widened from ₹1.46 cr to ₹2.20 cr.
A ₹2.31 crore loss in Q4 erased a marginal nine-month profit.
Auditors issued an unmodified opinion on the financial statements.

Why this matters

Flat revenue paired with a widening loss points to cost pressures or margin erosion at a company already too small to absorb them. The Q4 swing from marginal profit to a deep quarterly loss suggests something broke late in the fiscal year.

What we're watching

Management commentary on the Q4 deterioration.
Whether the cost pressures are one-off or structural.
Impact on the company's already thin balance sheet.

The full read

Centenial Surgical Suture is a ₹33 crore nano-cap. Its FY26 numbers tell a simple story: revenue didn't move, but the loss grew. Full-year sales held at ₹53.84 crore, yet the net loss widened 51% to ₹2.20 crore from ₹1.46 crore. The damage was concentrated in the final quarter. A ₹2.31 crore Q4 loss erased the marginal profit the company had built through the first nine months. Something shifted in the last three months of the fiscal year, and the result is a company earning no more than it did before, but losing more. The auditors signed off without qualification. The open question is what drove the Q4 deterioration.

Questions answered

How did a small profit through nine months turn into a full-year loss?: The company reported a ₹2.31 crore net loss in the fourth quarter alone. That single quarter's loss exceeded the marginal profit earned from April through December, pushing the full-year figure to a ₹2.20 crore loss.
How does the FY26 loss compare to the prior year?: The net loss widened from ₹1.46 crore in FY25 to ₹2.20 crore in FY26, a 51% increase, while revenue was flat at ₹53.84 crore.
Did the auditors raise any flags?: No. The statutory auditors issued an unmodified opinion, meaning they found the financial statements to be presented fairly in all material respects.
What is the company's market capitalization?: Centenial Surgical Suture is a nano-cap with a market capitalization of ₹33 crore.

Mentioned: Centenial Surgical Suture Ltd. · FY26 · Q4 ₹2.31 cr loss

Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Centenial Surgical Suture Ltd.

Pharmaceuticals

₹28 cr

Latest quarter · Mar 2026

Sales₹13 cr

Net profit−₹2 cr

Op. margin+7.4%

EPS−₹6.34

Strength & growth

Debt / equity0.40×

Current ratio1.98×

Sales CAGR+0.5%

Story so far

All notes on CSURGSU →

30 May 2026 · 9:35 PM IST Centenial Surgical Suture posts a ₹2.2 cr annual loss on flat revenue
41d ago Centenial Surgical Suture posts FY26 results, auditors sign off clean